ResMed Inc.
RMD
$277.05
$3.241.18%
NYSE
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 379.71M | 365.04M | 344.62M | 311.36M | 292.24M |
Total Depreciation and Amortization | 67.94M | 45.65M | 49.50M | 47.25M | 47.99M |
Total Amortization of Deferred Charges | 6.34M | 6.26M | 6.40M | 6.46M | 6.77M |
Total Other Non-Cash Items | 26.02M | 29.43M | 23.00M | 19.87M | 36.00M |
Change in Net Operating Assets | 58.76M | 132.28M | -114.90M | -59.40M | 57.13M |
Cash from Operations | 538.77M | 578.66M | 308.62M | 325.54M | 440.11M |
Capital Expenditure | -30.59M | -20.80M | -20.64M | -17.84M | -24.88M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -138.58M | 0.00 | -670.00K | -- | -19.70M |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 35.45M | -10.99M | -15.38M | 19.99M | -1.93M |
Cash from Investing | -133.71M | -31.79M | -36.69M | 2.15M | -46.51M |
Total Debt Issued | -- | -- | -- | -- | 0.00 |
Total Debt Repaid | -5.00M | 0.00 | -5.00M | -30.00M | -300.00M |
Issuance of Common Stock | 30.16M | 9.02M | 26.88M | 8.38M | 27.70M |
Repurchase of Common Stock | -100.60M | -75.39M | -91.72M | -50.39M | -50.43M |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -77.59M | -77.70M | -77.70M | -77.89M | -70.55M |
Other Financing Activities | -10.86M | 0.00 | 0.00 | -855.00K | 0.00 |
Cash from Financing | -163.89M | -144.07M | -147.54M | -150.76M | -393.28M |
Foreign Exchange rate Adjustments | 35.57M | 7.96M | -28.81M | 11.07M | 129.00K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 276.74M | 410.77M | 95.58M | 188.00M | 451.00K |